Mivebresib
#
-
Catalog numberB1564-25
-
Price:
-
Size25 mg
-
-
Alternative_nameN-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide; ABBV-075
-
DescriptionMivebresib is a potent BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo.
-
CAS Number1445993-26-9
-
Molecular FormulaC₂₂H₁₉F₂N₃O₄S
-
Molecular Weight459.47
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA potent BET inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID71600087
-
SMILESCCS(=O)(=O)NC1=CC(=C(C=C1)OC2=C(C=C(C=C2)F)F)C3=CN(C(=O)C4=C3C=CN4)C
-
InChiInChI=1S/C22H19F2N3O4S/c1-3-32(29,30)26-14-5-7-19(31-20-6
-
InChi KeyRDONXGFGWSSFMY-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameMivebresib
-
Alternative nameMivebresib
-